The PI3K-Akt, MAPK, and FoXO signal pathway may be implicated in the therapeutic mechanism of YQW in treating T2DM, according to a comprehensive analysis of 538 targets and 1,667 genes associated to T2DM from 22 blood components. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.